bedaquiline
CHEBI:CHEBI_72292
Definition
A quinoline-based antimycobacterial drug used (as its fumarate salt) for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria.
Chemical Information
- Molecular Formula
- C32H31BrN2O2
- Molecular Mass
- 555.50500
- Charge
- 0
- SMILES
- COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12
- InChI
- InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1
- InChIKey
- QUIJNHUBAXPXFS-XLJNKUFUSA-N
Alternative Names
- (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenylbutan-2-ol
- 1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol
- bedaquilina
- bedaquiline
- bedaquilinum
- R 207910
- R207910
- TMC 207
- TMC-207
- TMC207
Drug Classification
-
tertiary alcoholView Class →
CHEBI:26878
-
aromatic etherView Class →
CHEBI:35618
-
tertiary amino compoundView Class →
CHEBI:50996
-
naphthalenesView Class →
CHEBI:25477
-
quinolinesView Class →
CHEBI:26513
-
organobromine compoundView Class →
CHEBI:37141
-
t278966
-
t279852
-
t279921
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:72292
- DRON_00010000
- 1364504
- oboInOwl#hasDbXref
- Wikipedia:Bedaquiline
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:72292
- pharm_class
- Diarylquinoline Antimycobacterial [EPC]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1364504
- oboInOwl#hasDbXref
- Wikipedia:Bedaquiline
- oboInOwl#id
- CHEBI:72292
- rxcui
- 2373941
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- POWDER
- active_ingredient_strength
- 1 kg/kg
- marketing_start_date
- 20200527
- package_marketing_start_date
- 20200527
- labeler_name
- Janssen Products, LP
- manufacturer_name
- Janssen Products, LP
- generic_name
- Bedaquiline Fumarate
- brand_name
- SIRTURO
- brand_name_base
- SIRTURO
- product_ndc
- 59676-701
- application_number
- NDA204384
- spl_id
- 0c3a15ed-4221-576a-e063-6394a90a6477
- active_ingredient_name
- BEDAQUILINE FUMARATE
- package_ndc
- 59676-701-01
- package_description
- 188 TABLET in 1 BOTTLE (59676-701-01)
- unii
- P04QX2C1A5
- spl_set_id
- 1534c9ae-4948-4cf4-9f66-222a99db6d0e
- upc
- 0359676702603
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_33231
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_72706
- has_treatment
- http://purl.obolibrary.org/obo/DOID_401
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect33425
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_72706
- owl#annotatedSource
- t280217
- owl#someValuesFrom
- t3009670